HRP931504B1 - Novel peptides, their production and use - Google Patents

Novel peptides, their production and use

Info

Publication number
HRP931504B1
HRP931504B1 HR931504A HRP931504A HRP931504B1 HR P931504 B1 HRP931504 B1 HR P931504B1 HR 931504 A HR931504 A HR 931504A HR P931504 A HRP931504 A HR P931504A HR P931504 B1 HRP931504 B1 HR P931504B1
Authority
HR
Croatia
Prior art keywords
production
novel peptides
novel
peptides
chdcheco
Prior art date
Application number
HR931504A
Other languages
English (en)
Inventor
Andreas Haupt
Bernd Janssen
Kurt Ritter
Dagmar Klinge
Gerhard Keilhauer
Cynthia Romerdahl
Teresa Barlozzari
Xiao-Dong Quian
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HRP931504A2 publication Critical patent/HRP931504A2/xx
Publication of HRP931504B1 publication Critical patent/HRP931504B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Window Of Vehicle (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR931504A 1992-12-16 1993-12-16 Novel peptides, their production and use HRP931504B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99130992A 1992-12-16 1992-12-16

Publications (2)

Publication Number Publication Date
HRP931504A2 HRP931504A2 (en) 1997-02-28
HRP931504B1 true HRP931504B1 (en) 2001-04-30

Family

ID=25537082

Family Applications (1)

Application Number Title Priority Date Filing Date
HR931504A HRP931504B1 (en) 1992-12-16 1993-12-16 Novel peptides, their production and use

Country Status (24)

Country Link
US (1) US5502032A (cs)
EP (1) EP0674652B1 (cs)
JP (1) JPH08504415A (cs)
CN (1) CN1057095C (cs)
AT (1) ATE196296T1 (cs)
AU (1) AU679479B2 (cs)
BR (1) BR1100019A (cs)
CA (1) CA2151953A1 (cs)
CZ (1) CZ286752B6 (cs)
DE (1) DE69329425T2 (cs)
ES (1) ES2151921T3 (cs)
FI (1) FI952961A0 (cs)
HR (1) HRP931504B1 (cs)
HU (1) HUT72067A (cs)
IL (1) IL107987A (cs)
NO (1) NO952366L (cs)
NZ (1) NZ258882A (cs)
PL (1) PL178766B1 (cs)
RU (1) RU2132334C1 (cs)
SG (1) SG67935A1 (cs)
SI (1) SI9300661A (cs)
TW (1) TW400335B (cs)
WO (1) WO1994013695A1 (cs)
ZA (1) ZA939389B (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599902A (en) * 1994-11-10 1997-02-04 Arizona Board Of Regents Acting On Behalf Of Arizona State University Cancer inhibitory peptides
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US5741892A (en) * 1996-07-30 1998-04-21 Basf Aktiengesellschaft Pentapeptides as antitumor agents
US5939527A (en) * 1996-07-30 1999-08-17 Basf Aktiengesellschaft Tetrapeptides as antitumor agents
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en) 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6297233B1 (en) 1999-02-09 2001-10-02 Bristol-Myers Squibb Company Lactam inhibitors of FXa and method
US6323315B1 (en) 1999-09-10 2001-11-27 Basf Aktiengesellschaft Dolastatin peptides
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
HUP0304058A2 (hu) 2001-01-30 2004-04-28 Bristol-Myers Squibb Company Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
US20050065118A1 (en) * 2001-10-16 2005-03-24 Jing Wang Organosulfur inhibitors of tyrosine phosphatases
WO2003075853A2 (en) 2002-03-08 2003-09-18 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
CA2524511A1 (en) * 2003-05-12 2004-11-18 Pfizer Products Inc. Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
EP1765332A2 (en) * 2004-06-17 2007-03-28 Cengent Therapeutics, Inc. Trisubstituted nitrogen modulators of tyrosine phosphatases
WO2006017124A2 (en) * 2004-07-09 2006-02-16 Cengent Therapeutics, Inc. Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases
WO2006028970A1 (en) 2004-09-02 2006-03-16 Cengent Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
JP5171621B2 (ja) 2005-07-07 2013-03-27 シアトル ジェネティックス， インコーポレイテッド フェニルアラニン側鎖修飾をｃ末端に有するモノメチルバリン化合物
CA2837840C (en) 2011-06-10 2020-08-04 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
WO2014093379A1 (en) 2012-12-10 2014-06-19 Mersana Therapeutics, Inc. Auristatin compounds and conjugates thereof
US9522876B2 (en) 2013-03-15 2016-12-20 Zymeworks Inc. Cytotoxic and anti-mitotic compounds, and methods of using the same
SG11201605260VA (en) 2013-12-27 2016-07-28 Zymeworks Inc Var2csa-drug conjugates
ES2916722T3 (es) 2013-12-27 2022-07-05 Zymeworks Inc Sistemas de enlace que contienen sulfonamida para conjugados de fármacos
EP3194421B1 (en) 2014-09-17 2021-11-03 Zymeworks Inc. Cytotoxic and anti-mitotic compounds, and methods of using the same
US10517958B2 (en) 2016-10-04 2019-12-31 Zymeworks Inc. Compositions and methods for the treatment of platinum-drug resistant cancer
EP4400121A1 (en) 2021-09-03 2024-07-17 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3540495A1 (de) * 1985-11-15 1987-05-21 Merck Patent Gmbh Aminosaeurederivate
ATE94395T1 (de) * 1986-05-09 1993-10-15 Pulverer Gerhard Verwendung von spezifischen monosacchariden zur herstellung eines arzneimittels zur verhinderung von metastasen maligner tumore.
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
JP2714402B2 (ja) * 1988-07-13 1998-02-16 日清製粉株式会社 癌転移抑制剤
DK414389A (da) * 1988-08-24 1990-02-26 Merck & Co Inc Farmaceutisk praeparat indeholdende et aminosyrederivat med renin-inhibitorisk virkning
US4978744A (en) * 1989-01-27 1990-12-18 Arizona Board Of Regents Synthesis of dolastatin 10
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
US5138036A (en) * 1989-11-13 1992-08-11 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
SG87056A1 (en) * 1991-08-09 2002-03-19 Teikoku Hormone Mfg Co Ltd Novel tetrapeptide derivative

Also Published As

Publication number Publication date
AU679479B2 (en) 1997-07-03
PL309353A1 (en) 1995-10-02
TW400335B (en) 2000-08-01
HUT72067A (en) 1996-03-28
EP0674652B1 (en) 2000-09-13
US5502032A (en) 1996-03-26
FI952961A7 (fi) 1995-06-15
RU95115135A (ru) 1997-06-10
ES2151921T3 (es) 2001-01-16
CN1095724A (zh) 1994-11-30
EP0674652A1 (en) 1995-10-04
FI952961L (fi) 1995-06-15
CN1057095C (zh) 2000-10-04
ZA939389B (en) 1995-06-15
SI9300661A (en) 1994-06-30
CZ286752B6 (en) 2000-06-14
JPH08504415A (ja) 1996-05-14
CZ157595A3 (en) 1996-01-17
IL107987A (en) 1999-10-28
HU9501754D0 (en) 1995-08-28
NO952366D0 (no) 1995-06-15
NZ258882A (en) 1997-06-24
AU5695994A (en) 1994-07-04
SG67935A1 (en) 1999-10-19
HRP931504A2 (en) 1997-02-28
CA2151953A1 (en) 1994-06-23
WO1994013695A1 (en) 1994-06-23
DE69329425T2 (de) 2001-01-18
PL178766B1 (pl) 2000-06-30
FI952961A0 (fi) 1995-06-15
NO952366L (no) 1995-06-15
RU2132334C1 (ru) 1999-06-27
IL107987A0 (en) 1994-04-12
BR1100019A (pt) 2000-07-25
DE69329425D1 (de) 2000-10-19
ATE196296T1 (de) 2000-09-15

Similar Documents

Publication Publication Date Title
HRP931504A2 (en) Novel peptides, their production and use
MY124487A (en) Dolastatin derivatives, their preparation and use
HUT71398A (en) Derivatives of dolastatin
CA2111083A1 (en) Novel peptides, their preparation and use
ZA919752B (en) Fluorine compounds
TW224461B (cs)
MY114327A (en) Novel peptides, the preparation and use thereof
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
ES8606298A1 (es) 1.4-dihidropirazinas
GR74769B (cs)
AU4863993A (en) Tetrahydroindazolone pharmaceutical compositions

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20011216

Year of fee payment: 9

PBON Lapse due to non-payment of renewal fee

Effective date: 20021217